Liberty One Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Liberty One Investment Management's GILD Position: Q1 2026 in Review
Liberty One Investment Management increased its Gilead Sciences (GILD) stake by 4.2% in Q1 2026, buying an estimated $286K and bringing the position to 50,865 shares worth $7.09M. The position accounts for 0.73% of the portfolio, ranked #31.
Liberty One Investment Management first reported a position in GILD in Q1 2021 and has held it in 21 quarters since. The position peaked at $14.8M in Q4 2022. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Liberty One Investment Management held 50,865 shares of Gilead Sciences worth $7.09M as of Q1 2026.
- Liberty One Investment Management bought 2,041 Gilead Sciences shares in Q1 2026, an estimated $286K.
- Gilead Sciences made up 0.73% of Liberty One Investment Management's portfolio in Q1 2026, its #31 holding.
- Liberty One Investment Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 21 quarters since.
- Liberty One Investment Management's Gilead Sciences position peaked at $14.8M in Q4 2022.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Liberty One Investment Management's 13F filing for Q1 2026, filed 14 May 2026.